A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

According to Bloomberg News, Vinay Prasad, who oversees gene therapies at the FDA, said the plans will be published in early November. He foresees the approach sparking curiosity for the next wave of ...

Investors want their money to grow in some shape, form, or fashion with every stock they buy. However, I understand that ...

Intellia Therapeutics is featured in Cathie Wood's portfolio and has a high Wall Street price target. The company's leading candidates look somewhat promising, but one of them just hit a major setback ...

CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats, is a natural defense system in bacteria that scientists have adapted into a powerful gene-editing tool. This ...

Most current approaches rely on adding nuclear localization signal (NLS) motifs to the ends of Cas9 to facilitate nuclear entry. However, this method is inefficient, and much of the Cas9 that is ...

Virginia Tech scientists found that age-related memory loss stems from molecular changes in the brain. Memory decline might not be just a natural part of aging. Researchers at Virginia Tech have ...

Nantucket High School and the Egan Maritime Institute will bring island students to the Marine Biological Laboratory in Woods ...

Chocolate prices have been rising due to complications in the supply chain, but Penn State researchers have made a ...

In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...

Research from UChicago dissects how a single genetic switch helps butterflies mimic wing patterns of other species to protect ...

Eugenics in colonial Nigeria was not a historical footnote; it was a system of thought that still echoes in the country’s social hierarchies, educational systems, and conflicts. From the suppression ...